Yvonne Steffen
Philip Morris International (Switzerland), Osnabrück University
Papers
2
Total Citations
54
H-Index
2
About
Yvonne Steffen’s research bridges two distinct frontiers: the molecular mechanisms of cardiovascular disease and the development of socially assistive robotics for aging populations. Her early work in lipid metabolism, exemplified by the highly cited study “Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice” (2012, 52 citations), provided critical insights into how environmental factors like smoking reshape lipid profiles to accelerate atherosclerosis. This foundational contribution remains a key reference for researchers exploring lipid-driven vascular pathology. More recently, Steffen has pioneered the integration of robotics into geriatric care. As a lead investigator of the MORPHIA project (2020–2023), she developed a mobile robotic assistant that enables video-based communication networks for older and frail individuals living at home. Her 2025 paper on this system (2 citations, newly published) outlines how the robot facilitates real-time social care networking, addressing isolation and safety concerns. This work exemplifies her shift from bench science to translational engineering, demonstrating a rare versatility—from dissecting atherogenic lipidomes to designing human-robot interaction protocols. Steffen’s career underscores how rigorous biological research can inform, and be complemented by, compassionate technological innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2